Quarterly report · Q2
6776.TEDINET S100PKUV
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥19.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥266m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥19m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥445m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥355m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥81m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥464m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥92m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥329m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥246m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥20m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥311m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥37m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥23.3bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥21.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥19.9bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥13.9bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥13.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥9.3bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥8.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.7bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.8bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥472m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥831m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥456m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥544m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥545m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥399m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥19.39 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.23 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.47 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.23 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.66 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 33.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.2% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 42
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥59m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥59m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥26m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥430m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥389m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥40m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥65m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥9.1bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥9.1bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥18m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥107m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥143m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥143m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥117m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥11.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥59m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥263m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥19m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥19m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥3m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Americareportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥51m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥222m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥221m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥1m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Chinareportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥17m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥7.1bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥7.1bn |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥17m |
| jpcrp040300-q2r_E01813-000Injection Molding Business In Japanreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥163m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥144m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥144m |
| jpcrp040300-q2r_E01813-000Real Estate Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥117m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥8.6bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥8.6bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥19m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥22m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 501
| Item | Context | Value | Unit |
|---|---|---|---|
| Liabilities | CurrentQuarterInstant | 13903000000 | JPY |
| Capital stock | Prior1YearInstant | 1208000000 | JPY |
| Capital stock | CurrentQuarterInstant | 1208000000 | JPY |
| Capital surplus | Prior1YearInstant | 1034000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 1034000000 | JPY |
| Retained earnings | Prior1YearInstant | 4619000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 4898000000 | JPY |
| Treasury stock | Prior1YearInstant | -0 | JPY |
| Treasury stock | CurrentQuarterInstant | -0 | JPY |
| Shareholders equity | Prior1YearInstant | 6862000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 7141000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 112000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 102000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 87000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 440000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 200000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 543000000 | JPY |
| Non controlling interests | Prior1YearInstant | 1026000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 1663000000 | JPY |
| Net assets | Prior1YearInstant | 8089000000 | JPY |
| Net assets | CurrentQuarterInstant | 9348000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 21318000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 23251000000 | JPY |
| Net sales | Prior1YTDDuration | 8620000000 | JPY |
| Net sales | CurrentYTDDuration | 10896000000 | JPY |
| Cost of sales | Prior1YTDDuration | 7345000000 | JPY |
| Cost of sales | CurrentYTDDuration | 9148000000 | JPY |
| Gross profit | Prior1YTDDuration | 1274000000 | JPY |
| Gross profit | CurrentYTDDuration | 1748000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 1255000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 1481000000 | JPY |
| Operating income | Prior1YTDDuration | 19000000 | JPY |
| Operating income | CurrentYTDDuration | 266000000 | JPY |
| Interest income noi | Prior1YTDDuration | 0 | JPY |
| Interest income noi | CurrentYTDDuration | 0 | JPY |
| Dividends income noi | Prior1YTDDuration | 4000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 5000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 15000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 158000000 | JPY |
| Compensation income noi | Prior1YTDDuration | 53000000 | JPY |
| Compensation income noi | CurrentYTDDuration | 16000000 | JPY |
| Other noi | Prior1YTDDuration | 12000000 | JPY |
| Other noi | CurrentYTDDuration | 17000000 | JPY |
| Non operating income | Prior1YTDDuration | 87000000 | JPY |
| Non operating income | CurrentYTDDuration | 198000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 24000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 17000000 | JPY |
| Other noe | Prior1YTDDuration | 0 | JPY |
| Other noe | CurrentYTDDuration | 1000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 25000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |